INTRODUCTION {#SEC1}
============

Super-enhancers (SEs) are enhancer clusters bound by master transcription factors. SEs affect the transcriptional activation of most genes, and participate in disease development, cell differentiation and tissue type identity specification. SEs differ from typical enhancers in terms of a larger size and transcription factor density, a tendency to strongly activate transcription and robustness to perturbation ([@B1]). SEs can regulate gene expression and specify cell type ([@B2]). SEs play key roles in cancer cell maintenance and impact oncogene transcriptional processes. Cancer cell dependence on SE transcriptional and proliferative activities may provide a fatal weakness in targeted-cell therapy design. Understanding the content and mechanism of the SE complex will facilitate the study of drug-targeted-cell cancer therapy ([@B5]).

Several methods are available for SE identification, including computational and experimental technologies ([@B6]). Computational methods can identify a large number of SEs in a short time, whereas experimental methods can clarify SE mechanism and activity ([@B7]). Studies have shown that nucleosomes with the histone modification H3K27ac are enriched at active enhancers ([@B8],[@B9]). H3K27ac datasets identified using Chromatin Immunoprecipitation sequencing (ChIP-Seq) helped identify the majority of known SEs; the modification seems to be a signature of SEs ([@B3]), as well as Med1 ([@B10]). Moreover, BRD4, which belongs to the bromodomain and extra-terminal domain (BET) family, has been identified in many studies as an epigenetic regulator that can affect cell transcription ([@B11]). The coactivator p300 is a histone acetyl-transferase that can recruit the transcription initiation complex to initiate transcription and may impact protein ubiquitination modification and degradation ([@B12],[@B13]). H3K27ac modification, BRD4, Med1 and p300 associations, are all enriched in SEs compared with typical enhancers, as shown by ChIP-Seq data. We consider the existence of these four factors to be an essential signature for computationally recognizing SEs. The rapid growth of publicly available H3K27ac, BRD4, Med1 and p300 ChIP-Seq datasets stored in Gene Expression Omnibus (GEO), Sequence Read Archive (SRA) and ENCODE ([@B14]) provides an excellent opportunity to computationally identify SEs in multiple cell types and tissues using ChIP-Seq datasets.

Researchers have developed several databases for the storage of SE data in the past. In 2015, we proposed and built a database named the Super Enhancer Archive (SEA v. 1.0 <http://sea.edbc.org>), with the aim to provide a comprehensive archive of super-enhancers in numerous species ([@B15]). dbSUPER provides a SE list from the mouse and human genome ([@B16]). SEdb is designed to store resources on human SEs ([@B17]), and SELER recognizes SE associated lncRNA in human cancer cell lines ([@B18]). Most of these functions were designed to computationally identify and store SEs, but not for the functional analysis of SEs. To this end, we updated the Super Enhancer Archive to version 3.0 (SEA v. 3.0, <http://sea.edbc.org>), which integrates SE data with regulatory elements, and provides comprehensive annotation regarding the formation and potential roles in the regulation of cell identity and associated effects after targeted editing. SEA v. 3.0 stores the SEs and conventional enhancers of 266 cell types, tissues and diseases across 11 species; provides optimized query criteria to comprehensive SE information; provides an updated multi-omics visualization genome browser; evaluates the specificity of SE cell type by Shannon Entropy; and provides the Enrichr enrichment analysis interface ([@B19]) for SE related genes. Additionally SEA v. 3.0 provides comprehensive regulatory element access. This includes ref-genes; CpG islands; H3K27ac, BRD4 and p300 landscapes; SE constituents; methylation and expression levels; transcription factor binding sites; relative conservation across the 11 species; SpCas9 target sites; SNP sites; and spatial interactions by High-throughput/resolution chromosome conformation capture (Hi-C); all available for customized data visualization across multiple cell types, tissues and disease states. In brief, SEA v. 3.0 provides a comprehensive platform for the storage, annotation, query, functional analysis and visualization of SEs.

DATA EXPANSION AND PRE-PROCESSING {#SEC2}
=================================

SEA v3.0 is a comprehensive database that provides criteria query, genome browser, personalized analysis tools and data downloads of SEs. An overview of SEA v3.0 is shown in Figure [1](#F1){ref-type="fig"}. H3K27ac, BRD4, Med1 and p300 datasets by ChIP-Seq of 266 cell types/tissues/diseases for 11 species were collected from the public ENCODE, GEO and SRA databases. This is a major expansion of the previous version, which contained 134 cell types in four species, with only H3K27ac ChIP-Seq datasets used for SE identification. Bowtie2 (v. 2.2.5) ([@B20]) and ROSE ([@B21]) were used to map ChIP-Seq reads to reference genomes and obtain candidate SEs for SEA v. 3.0 for 11 species: human (hg38), mouse (mm10), *D. melanogaster* (dm6), *C. elegans* (ce10), zebrafish (danRer11), chicken (galGal5), chimp (panTro5), rhesus (rheMac8), sheep (oviAri3), xenopus tropicalis (xenTro9) and stickleback (gasAcu1). Peaks located within a ±2 kb region of any RefSeq annotated gene promoter, or that overlapped with any ENCODE blacklisted genomic regions were excluded.

![Database content and construction. SEA v. 3.0 takes advantage of available public H3K27ac, BRD4, Med1 and p300 ChIP-Seq datasets to identify super-enhancers in different cell types/tissues/diseases of 11 species. It excludes peaks located within ±2 kb of any RefSeq annotated gene promoter or peaks overlapping with ENCODE blacklisted genomic regions. Multiple track types are used for genomic visualization including functional components generated by Hi-C datasets. Shannon Entropy is used to calculate and evaluate the cell type specificity of super-enhancers, and all data are accessible through the download page.](gkz1028fig1){#F1}

In this way, we incorporated 164 545 SEs and 3 361 785 enhancers computationally predicted in 266 cell types, tissues or diseases from 11 species. In detail, for human, 109 447 SEs were computationally predicted in 133 cell types, including 93 870 identified by H3K27ac, 10437 by p300, 4195 by BRD4 and 942 by Med1. For mouse, 23 964 SEs were identified in 39 cell types or tissues, including 19 721 identified by H3K27ac and 4243 by p300. Detailed SE statistics are shown in [Supplementary Table S1](#sup1){ref-type="supplementary-material"}. In addition, we manually curated experimentally supported SE data by strict experimental method through a review of more than 500 published papers. These papers were collected using keyword 'super enhancer' from PubMed. A total of 52 SE-related genes were obtained whose transcription affected by perturbation of relevant SEs ([Supplementary Table S2](#sup1){ref-type="supplementary-material"}). We provide 610 datasets including the super-enhancer information processed by SEA v. 3.0 and linkage of raw data source that were all reprocessed for super-enhancer identification and genome browser visualization in the download page. Data expansion and updating points are also shown in Table [1](#tbl1){ref-type="table"}.

###### 

SEA v3.0 data content compared with previous version of SEA

  Content                                                     SEA       SEA v3.0                 Fold increase
  ----------------- ----------------------------------------- --------- ------------------------ ---------------
  Super-enhancers   Species                                   4         11                       2.75
                    Recognition factor                        H3K27ac   H3K27ac,BRD4,p300,Med1   4
                    Super-enhancer                            83 996    164 545                  1.96
                    Enhancer                                  No        3 361 785                New
                    Experimental confirmed SEs                3         52                       17.33
                    Cell types/tissues/disease                134       266                      2.0
  Genome browser    DNA methylation                           26        37                       1.42
                    H3K27ac                                   194       208                      1.07
                    Expression                                35        87                       2.49
                    TF ChIP-seq data                          98        126                      1.29
                    4D genome                                 No        Yes                      New
                    SE constituent                            No        32                       New
                    Reference genome                          4         11                       2.75
                    CpG islands                               4         11                       2.75
                    SNP                                       Yes       Yes                      New
                    Transcription factor binding sites        Yes       Yes                      New
                    CRISPR-Cas9                               Yes       Yes                      New
                    p300                                      No        34                       New
                    BRD4                                      No        2                        New
                    Conservation                              Yes       Yes                      New
                    Genome position                           Yes       Yes                      New
  Analysis tools    GREAT                                     Yes       Yes                      \-
                    Enrichr                                   No        Yes                      New
                    Specific analysis of H3K27ac status       Yes       Yes                      \-
                    SE cell type specificity                  No        Yes                      New
                    TF enrichment analysis                    Yes       Yes                      New
                    Regulatory network                        Yes       Yes                      New
                    Query                                     Yes       Yes                      New
                    Data Downloads                            Yes       Yes                      New
  Others            Publications related to super-enhancers   8         52                       6.5

UPDATE OF DATABASE MODULES {#SEC3}
==========================

Searching engine update {#SEC3-1}
-----------------------

Our search engine was enhanced in SEA v. 3.0 to support additional accuracy. In addition to our original query options (species, genome location, gene name, cell types or tissues, SE name and transcription factors), three new options namely 'recognition factors', 'searching for Es or SEs' and 'Coding/Noncoding' have been added to help users query the specifying SEs with coding or noncoding related genes (Figure [2A](#F2){ref-type="fig"}). The results are displayed on a search result page that contains, the SEID (the identity number of SE), SE genomic loci, SE name and associated recognition factors. A new tool, Enrichr, was added for enrichment analysis using SE related genes, by which users can generate a download page of SE related genes or redirect those genes to the Enrichr database for enrichment analysis. GREAT ([@B22]) analysis of specified SEs is also provided in SEA v. 3.0.

![SEA v. 3.0 update modules. (**A**) Searching engine updates added three query options. (**B**) New track types updates include SE constituent computed by Hi-C in multiple cell types and 4D Genome.](gkz1028fig2){#F2}

Genome browser update {#SEC3-2}
---------------------

Nearby genes and SEs overlapped with user-specified genomic regions are presented in the SEA browser pages, together with related CpG islands, nucleotide conservation among 11 species and chromosomal location, all visualized by default. Furthermore, the H3K27ac modification states of 208 cell types, DNA methylation of 37 cell types, mRNA level of 87 cell types, SNPs, transcription factor binding measured by ChIP-Seq of 126 cell types and CRISPR/Cas9 target sites in the input genomic regions can be visualized manually. The BRD4-binding sites in two cell types, and p300-binding sites in 34 cell types are also available for visualization.

Hi-C was designed to capture genome-wide chromatin interactions and reveal the 3D structure of the genome; this may show possible regulatory interactions between genes. It is based on the cross-linking of DNA fragments with long linear distances but close spatial structure, and then an enrichment of cross-linked DNA fragments, and executed using high-throughput sequencing. We obtained Hi-C datasets of 32 human cell types from GEO. The raw fastq format files were aligned using bowtie2; then peak calling was executed by MACS ([@B23]), a software designed for model-based analysis of ChIP-Seq. These datasets are available as the 'SE Constituent' browser view track for visualization, and provide hypothetical information regarding genome-wide chromatin interactions within the user specified genomic region. Furthermore, we also integrated the 3C, 4C, 5C, ChIA-PET, Capture-C and IM-PET data from the 4DGenome project. These data can be visualized as the '4DGenome' browser view track to inquire about chromatin spatial interactions (Figure [2B](#F2){ref-type="fig"}).

Enhanced functional analysis tools {#SEC3-3}
----------------------------------

Three existing online SE analysis tools were further enhanced in SEA v. 3.0 that (i) builds bed files of specified SEs for download and GREAT analysis; (ii) calculates H3K27ac status specificity, which is represented by the mean value of histone modifications in the SE regions across the selected cell types; (iii) performs enrichment analysis of transcription factors in specified SEs. Our enhanced functional analysis tools provide powerful and robust performance in annotating SEs across various dimensions.

Newly developed functional analysis tool for SE cell type specificity {#SEC3-4}
---------------------------------------------------------------------

Cell type specificity is prominently characteristic of SEs, and is very important for cell type identity. To facilitate measurement of this feature, a new tool was developed to quantify the specificity of SEs across selected cell types by Shannon Entropy, which was employed to solve the problem of measuring information in a quantitative fashion. We assign:$$\documentclass[12pt]{minimal}
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A CASE APPLICATION SHOWING SELECT SEA V. 3.0 FEATURES {#SEC4}
=====================================================

Chromosome 1 SEs of the human HepG2 cell line that are computationally recognized by p300 were searched, and 12 records were returned (Figure [3A](#F3){ref-type="fig"}). We then performed enrichment analysis of these SE-related genes using Enrichr through the interface provided on the result page. Enrichr returns multiple types of enrichment information, including transcription, pathways, ontologies and disease/drug interactions. For example, these SE-related genes enrich for the positive regulation of developmental processes, the regulation of α--β T-cell differentiation, and the regulation of natural killer cell activation, which may all potentially affect tumor progression (Figure [3B](#F3){ref-type="fig"} and [Supplementary Figure S1](#sup1){ref-type="supplementary-material"}). Next we visualized the genomic region 'chr1:156086236--256106592,' which includes two SEs on the search result page. This region shows a high density of H3K27ac, p300, Brd4 and SE constituents in the HepG2 cell line (Figure [3D](#F3){ref-type="fig"}). We also provide the custom data visualization ([Supplementary Figure S2](#sup1){ref-type="supplementary-material"}). The spatial interactions of the region by Hi-C or ChIA-PET provide strong evidence for the functional targets of two SEs (Figure [3E](#F3){ref-type="fig"}). Finally, the cell-type specificity of H3K27ac was calculated by Shannon Entropy and measured for five SEs of HepG2 across 22Rv1, A549, A673, ACC112, Aorta, H9 and HepG2 cell lines. As shown in Figure [3C](#F3){ref-type="fig"}, A549 has high H3K27ac modification in seven of nine SEs computed, and HepG2 has modification in all nine SEs. Shannon Entropy is calculated for every SE across selected cell types. The more the value close to 0, the more specificity the SE is. Specifically, the HepG2 cell line specific SE shows high cell type specificity (close to 0) and may associate with the development of cancer (Figure [3C](#F3){ref-type="fig"} and [Supplementary Figure S3](#sup1){ref-type="supplementary-material"}).

![A case application showing select SEA v. 3.0 features. (**A**) Super-enhancers with related coding genes computationally recognized by p300 in chromosome 1 of the human HepG2 cell line. (**B**) Enrichment analysis of super-enhancer related genes through the Enrichr interface. (**C**) Cell type specificity of super-enhancers computed by Shannon Entropy. (**D**) H3K27ac, p300 and Brd4 density of HepG2 super-enhancers visualized in the genome browser. (**E**) Spatial interaction visualization by Hi-C in the genome region 'chr1:156864585--156975979'.](gkz1028fig3){#F3}

FUTURE DEVELOPMENT {#SEC5}
==================

The importance of SEs is now widely accepted, especially in physiological and pathological processes, such as development and disease. To support the in-depth study of SEs, we will constantly strive to update SEA and improve database functionality to provide a SE database concentrating on multiple species and requirements. Additional information related to SEs will be added to the database as it becomes available. With this continuous data update, SEA is ensured to be timeless. In particular, more detailed cell subtypes are being identified with the rapid development of single-cell research. For example, SE identification based on single-cell ChIP-seq technology is expected in the nearby future. We plan to add more and more -omics data as we update SEA, such that more and more researchers will be able use it.

Supplementary Material
======================

###### 

Click here for additional data file.
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